pocketful logo light
pocketful logo light
Alembic Ltd logo

Alembic Ltd

NSE: ALEMBICLTD BSE: 506235

₹87.27

(2.86%)

Sat, 30 May 2026, 08:23 am

Alembic Share Price Live Chart

1 Day

(2.86%)

No Result Found

Summary

  • Market Cap

    2256.34

  • Net Profit

    144.57

  • P/B

    1.08

  • Sector P/E

    31.87

  • P/E

    8.14

  • EV/EBITDA

    15.06

  • Debt/Equity (Industry)

    1.04

  • Interest Cover (Industry)

    1963.29

  • ROCE (Industry)

    0.14

  • RONW (Industry)

    0.18

  • ROE

    6.39

  • ROCE

    6.90

  • Debt/Equity

    0.01

  • EPS (TTM)

    12.36

  • Dividend Yield

    2.73

  • Book Value

    95.22

  • Interest Cover

    63.96

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are thoroughly covered by earnings (21.4x coverage).
  • Alembic is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Alembic is profitable, therefore cash runway is not a concern.
  • Alembic is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Alembic's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Alembic's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Alembic is not covered by any analysts.
  • Alembic has significant price volatility in the past 3 months.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters70.8870.8870.8870.8870.88
FII1.251.281.371.501.65
DII0.050.050.050.050.05
Public27.8227.7927.6927.5727.42
Government00000

Read More

Technical Analysis

RSI

45.58

MACD

-0.47

50 DMA

86.49

200 DMA

96.32

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic131.92109.01100.1086.1077.1963.1940.28
Fibonacci109.01100.2694.8586.1077.3571.9463.19
Camarilla97.5095.4093.3086.1089.1087.0084.90

Pivots Level: Classic

R3

+45.82

131.92

R2

+22.91

109.01

R1

+14.01

100.10

86.10
86.10
Pivot Point
LTP: 87.64

S1

-8.90

77.19

S2

-22.91

63.19

S3

-45.82

40.28

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    88.28

  • 20-EMA

    88.96

  • 30-EMA

    88.95

  • 50-EMA

    89.03

  • 100-EMA

    90.96

  • 200-EMA

    95.71

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
19 May 2026board-meetingsAccounts, Quarterly Results, Dividend
12 Feb 2026board-meetingsQuarterly Results, Nine Months Results
10 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
05 Jul 2025dividendFinal Dividend - Rs. - 2.405 Aug 2025
04 Jul 2025agm
13 May 2025dividend₹2.40 Dividend /Share05 Aug 2025
05 Jul 2024dividendFinal Dividend - Rs. - 2.405 Aug 2024
14 Jun 2024agm
13 May 2024dividend₹2.40 Dividend /Share05 Aug 2024
03 Jul 2023dividendFinal Dividend - Rs. - 2.203 Aug 2023

Read More

Peer Comparison

Alembic Ltd logo

Alembic Ltd

Lodha Developers Ltd logo

Lodha Developers Ltd

Prestige Estates Projects Ltd logo

Prestige Estates Projects Ltd

DLF Ltd logo

DLF Ltd

Phoenix Mills Ltd logo

Phoenix Mills Ltd

Oberoi Realty Ltd logo

Oberoi Realty Ltd

Read More

Alembic Ltd About

Alembic is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.

Industry

Construction

Founded

1907

Headquarters

CEO

Chirayu R Amin

Employees

Contact

Website icon

Website

http://www.alembiclimited.com

Email icon

Email

alembic.investors@alembic.co.in

Phone icon

Phone

91-0265-2280550

Location icon

Location

Alembic Road, , Vadodara, Gujarat, 390003

Read More

Alembic Ltd Company History

YearHistory
2012
  • Appointed Chandrashekhar P. Buch as Additional Non-Executive Independent Director.
2013
  • Allotted 13,35,15,914 bonus equity shares in 1:1 ratio.
  • Appointed R. C. Saxena as Additional Non-Executive Independent Director.
  • Recommended dividend of Re. 0.20 (10%) per equity share of Rs. 2.
2014
  • Recommended dividend of Re. 0.15 (7.5%) per equity share of Rs. 2.
2018
  • HGS won NASSCOM Customer Service Excellence Award 2018 in Transformation Category.
2020
  • Received USFDA approval for generic ophthalmic solution.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkSell136688998.2114 May 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy136688998.1314 May 2024
CRONY VYAPAR PVT LTDbulkBuy182080982.6830 Oct 2023
CRONY VYAPAR PVT LTDbulkSell174510782.7630 Oct 2023
CRONY VYAPAR PVT LTDbulkBuy125995281.1427 Oct 2023
CRONY VYAPAR PVT LTDbulkSell130995281.1927 Oct 2023
GRAVITON RESEARCH CAPITAL LLPbulkSell132633478.1226 Oct 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy132633478.2726 Oct 2023
CRONY VYAPAR PVT LTDbulkBuy181873278.4526 Oct 2023
CRONY VYAPAR PVT LTDbulkSell168970878.3726 Oct 2023

Read More

Alembic Ltd News

Alembic Q4 Net Profit Falls to 96M Rupees YoY

Alembic reports Q4 consolidated net profit of 96M rupees vs 238M YoY, with revenue at 600M rupees vs 603M and EBITDA margin contracting to 33.66% from 45.35%.

19 May 2026

companies

Alembic Ltd Board Meet on May 19 for Q4FY26 Results

Alembic Limited schedules its Board of Directors meeting on May 19, 2026, to consider audited financial results for Q4FY26 and recommend dividend on equity shares.

08 May 2026

companies

Alembic Launches Second 100-Day 'Saksham Niveshak' Campaign

Alembic Limited initiates Second 100-Day Campaign 'Saksham Niveshak' from April 1 to July 9, 2026, to facilitate dividend claims and KYC updates for shareholders to prevent transfer to IEPFA.

22 Apr 2026

companies

Alembic Launches Second 100-Day 'Saksham Niveshak' Campaign

Alembic Limited initiates Second 100-Day Campaign 'Saksham Niveshak' from April 1 to July 9, 2026, to facilitate dividend claims and KYC updates for shareholders to prevent transfer to IEPFA.

18 Apr 2026

companies

Alembic Opens Special Window for Physical Securities Transfer

Alembic Limited announces special window from February 5, 2026 to February 4, 2027 for transfer and dematerialization of physical securities sold/purchased before April 1, 2019.

15 Apr 2026

companies

Read More